pharma · Major Depressive Disorder (MDD), with or without Anxious Distress · Major Depressive Disorder (MDD) · SPTX
Seaport Therapeutics
Seaport Therapeutics clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Boston, USA HQ
68 Employees
Public company Type
SPTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 68
- Programs
- 3
- Drugs
- 3
- Patents
- 1
Seaport Therapeutics projects
3 ClinicalTrials.gov programs sponsored by Seaport Therapeutics.
Seaport Therapeutics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Seaport Therapeutics have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.